ThinkSabio

$PFE

$28.55▲ +0.6% YTD

14 SEC 13D/G filings tracked · Last updated Oct 14, 2026

Filing History
News
PFE ▲ +0.6% - Pfizer Inc.
CP $28.55▲ +0.6%Oct 14, 2026 · ThinkSabio Blog

$PFE - Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026…

News
PFE ▲ +2.3% - Pfizer Inc.
CP $28.11▲ +2.3%Oct 7, 2026 · ThinkSabio Blog

$PFE - Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer…

News
PFE ▲ +2.1% - Pfizer Inc.
CP $28.08▲ +2.1%Oct 7, 2026 · ThinkSabio Blog

$PFE Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer…

News
PFE ▲ +0.3% - Pfizer Inc.
CP $27.50▲ +0.3%Oct 6, 2026 · ThinkSabio Blog

$PFE - Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026…

News
PFE ▲ +0.3% - Pfizer Inc.
CP $27.49▲ +0.3%Oct 6, 2026 · ThinkSabio Blog

$PFE - Pfizer Declares Fourth-Quarter 2026 Dividend…

News
PFE ▼ -1.2% - Pfizer Inc.
CP $27.76▲ -1.2%Oct 2, 2026 · ThinkSabio Blog

$PFE - Pfizer’s LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo…

News
PFE ▼ -1.2% - Pfizer Inc.
CP $27.76▲ -1.2%Oct 2, 2026 · ThinkSabio Blog

$PFE PFIZER'S LITFULO MEETS CO-PRIMARY ENDPOINTS IN VITILIGO…

News
PFE ▼ -0.5% - Pfizer Inc.
CP $28.40▲ -0.5%Oct 1, 2026 · ThinkSabio Blog

$PFE Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study. The study met its primary endpoint, demonstrating a statistically…

News
PFE ▼ -0.5% - Pfizer Inc.
CP $28.59▲ -0.5%Oct 1, 2026 · ThinkSabio Blog

$PFE - Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study…

News
PFE ▼ -0.0% - Pfizer Inc.
CP $28.68▲ -0.0%Sep 28, 2026 · ThinkSabio Blog

$PFE - Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO…

News
PFE ▼ -1.3% - Pfizer Inc.
CP $27.37▲ -1.3%Sep 15, 2026 · ThinkSabio Blog

$PFE - Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference…

News
PFE ▼ -1.4% - Pfizer Inc.
CP $28.04▲ -1.4%Sep 8, 2026 · ThinkSabio Blog

$PFE - Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference…

News
PFE ▼ -0.9% - Pfizer Inc.
CP $28.05▲ -0.9%Aug 27, 2026 · ThinkSabio Blog

$PFE PFIZER AND BIONTECH RECEIVE U.S. FDA APPROVAL FOR XFG-ADAPTED COVID-19 VACCINE…

News
PFE ▼ -0.9% - Pfizer Inc.
CP $28.05▲ -0.9%Aug 27, 2026 · ThinkSabio Blog

$PFE Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine…